Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Kidney Biopsy Market?

The size of the kidney biopsy market has experienced robust growth in recent years. Projected to expand from $2.14 billion in 2024 to $2.26 billion in 2025, the market’s Compound Annual Growth Rate (CAGR) stands at 5.6%. The historic period’s growth can be credited to factors such as elevated levels of chronic kidney diseases, increased consciousness about early detection, a burgeoning elder population, enlargement of healthcare structures, heightened government efforts towards managing kidney disease, and an uplift in kidney health awareness.

In the forthcoming years, the kidney biopsy market is projected to register substantial growth, reaching $2.75 billion in 2029 with a compound annual growth rate of 5.0%. The factors driving this expansion during the forecasted period consist of a rising number of kidney disease incidents, heightened spending on healthcare, increased recognition of the importance of early diagnosis, a larger senior population, a growing preference for less-invasive procedures, and an upward trend in research activities. Prominent trends expected to emerge during the forecast period encompass progress in biopsy techniques, the rising adoption of less invasive procedures, enhancements in imaging technology, the incorporation of artificial intelligence for improved accuracy, and novel tech developments in biopsy devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Growth Drivers Are Shaping The Kidney Biopsy Market Outlook?

The anticipated increase in renal cancer incidences is set to stimulate the expansion of the kidney biopsy market. Renal cancer involves unchecked proliferation of irregular kidney cells, a situation that can be attributed to lifestyle changes, environmental toxins, and improved detection methods that facilitate increased diagnoses. Kidney biopsies are instrumental in diagnosing and managing renal cancer by affirming the existence of cancer cells, figuring out the cancer grade, designing treatments, observing treatment reactions, and availing prognostic data. For example, as per the projections of Cancer Research UK, a major cancer research establishment in the UK, the novel kidney cancer incidences are expected to surge from roughly 16,300 in 2023 to around 21,900 in 2025. Hence, the kidney biopsy market’s expansion is being fueled by the growing incidences of renal cancer.

What Are The Primary Segmentation Parameters In The Kidney Biopsy Market?

The kidney biopsymarket covered in this report is segmented –

1) By Type: Percutaneous Biopsy; Surgical Biopsy

2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria

3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy; CT-Guided Biopsy; MRI-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy; Laparoscopic Kidney Biopsy

How Are Industry Trends Steering The Expansion Of The Kidney Biopsy Market?

Leading firms in the kidney biopsy market are at the forefront of creating novel systems that combine artificial intelligence (AI) for bolstering diagnostic precision, refining procedures, and enhancing the results for patients. AI fortifies kidney biopsy procedures by optimizing image analysis, supplementing diagnostic assistance, facilitating treatment plans, providing predictive analytics, and propelling research into kidney ailments. For instance, Aiosyn, a software company based in Netherlands, introduced the NephroPath platform in March 2024. This platform utilizes computational pathology algorithms to evaluate histological biomarkers in kidney biopsies, encompassing the identification of tissue types, calculation of interstitial fibrosis, and accurate counting and assessment of glomeruli. The assurance of uniformity, meticulousness, and reproducibility of renal pathology biomarkers scoring through this AI-assisted analysis surmounts the limitations of conventional scoring techniques and observer bias.

Which Organizations Are At The Forefront Of The Kidney Biopsy Market?

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Holds The Greatest Opportunity For Kidney Biopsy Market Expansion?

North America was the largest region in the kidney biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2025, By The Business Research Company

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model